Clearmind Medicine (CMND) Intangibles (2021 - 2026)
Clearmind Medicine (CMND) posted quarterly Intangibles of $91940.0 for Q2 2026, down 10.65% year-over-year from $102894.0 in Q2 2025, and down 2.82% quarter-over-quarter from $94611.0 in Q1 2026.
Clearmind Medicine (CMND) Intangibles (2021 - 2026) Analysis & Trends
Clearmind Medicine's Intangibles history runs 6 years deep, the most recent figure standing at $91940.0 for Q2 2026.
- In Q2 2026, Intangibles fell 10.65% year-over-year to $91940.0; the TTM figure through Apr 2026 stood at $91940.0 (down 10.65% YoY), while the FY2025 annual figure was $97372.0, down 10.11% from the prior year.
- Intangibles for Q2 2026 stood at $91940.0, down from $94611.0 in the prior quarter.
- The five-year high for Intangibles was $133862.5 in Q4 2022, with the low at $91940.0 in Q2 2026.
- The 5-year median for Intangibles is $111087.0 (2024), against an average of $111161.7.
- The sharpest annual moves came in 2022 and 2024: Intangibles dropped 15.02% in 2022, then dropped 5.66% in 2024.
- Clearmind Medicine's Intangibles stood at $133862.5 in 2022, then dropped by 10.87% to $119310.0 in 2023, then fell by 9.21% to $108326.0 in 2024, then retreated by 10.11% to $97372.0 in 2025, then declined by 5.58% to $91940.0 in 2026.
- Business Quant data shows CMND's Intangibles at $91940.0 in Q2 2026, $94611.0 in Q1 2026, and $97372.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Clearmind Medicine | 540,485.35 | -13.05 Mn | - | 91,940.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 91,940.00 |
| Jan 31, 2026 | 94,611.00 |
| Oct 31, 2025 | 97,372.00 |
| Jul 31, 2025 | 100,133.00 |
| Apr 30, 2025 | 102,894.00 |
| Jan 31, 2025 | 105,565.00 |
| Oct 31, 2024 | 108,326.00 |
| Jul 31, 2024 | 111,087.00 |
| Apr 30, 2024 | 113,848.00 |
| Jan 31, 2024 | 116,549.00 |
| Oct 31, 2023 | 119,310.00 |
| Jul 31, 2023 | 117,755.00 |
| Apr 30, 2023 | 125,289.00 |
| Jan 31, 2023 | 128,884.01 |
| Oct 31, 2022 | 133,862.55 |
| Oct 31, 2021 | 157,527.70 |